CC
BMY icon

Corsicana & Co’s Bristol-Myers Squibb BMY Stock Holding History

Corsicana & Co’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17.9K Buy
+310
New +$17.8K 0.01% 200

Other funds holding BMY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
SAM
SEB Asset Management Stockholm $26.6B AUM
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

Corsicana & Co's BMY Position: Q2 2026 in Review

Corsicana & Co opened a new position in Bristol-Myers Squibb (BMY) in Q2 2026: 310 shares worth $17.9K. The stake represents 0.01% of the portfolio and ranks #200 among its holdings.

1,301 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Corsicana & Co held 310 shares of Bristol-Myers Squibb worth $17.9K as of Q2 2026.
  • Bristol-Myers Squibb was a new Corsicana & Co position in Q2 2026.
  • Bristol-Myers Squibb made up 0.01% of Corsicana & Co's portfolio in Q2 2026, its #200 holding.
  • 1,301 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Corsicana & Co's 13F filing for Q2 2026, filed 24 Jul 2026.